Zolmitriptan

Chemical formula: C₁₆H₂₁N₃O₂  Molecular mass: 287.357 g/mol  PubChem compound: 60857

Therapeutic indications

Zolmitriptan is indicated for:

Treatment of migraine headache with or without aura

Population group: only adults (18 - 65 years old)

Migraine

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Zolmitriptan is contraindicated in the following cases:

Moderate or severe hypertension, mild uncontrolled hypertension

Hypertension

Ischaemic heart disease, coronary vasospasm, peripheral vascular disease

at least one of
Ischemic heart disease
Prinzmetal angina
Peripheral vascular disease

History of cerebrovascular accident, history of transient ischaemic attack

at least one of
H/O: CVA
History of transient ischemic attack

Creatinine clearance of less than 15 ml/min

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Wolff-Parkinson-White syndrome, arrhythmias associated with other cardiac accessory conduction pathways

at least one of
Ventricular pre-excitation with arrhythmia
Accelerated atrioventricular conduction

Ergotamine

Ergotamine

Lactation

Lactation

5-HT1B/1D agonists

Selective serotonin (5HT1) agonists

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.